Copyright
©The Author(s) 2021.
World J Gastrointest Surg. Sep 27, 2021; 13(9): 1000-1011
Published online Sep 27, 2021. doi: 10.4240/wjgs.v13.i9.1000
Published online Sep 27, 2021. doi: 10.4240/wjgs.v13.i9.1000
Figure 2 Oncological outcomes according to the status of adjuvant chemotherapy in patients with ypT0–1 rectal cancer after preoperative chemoradiotherapy.
A: Recurrence-free survival; B: Overall survival. ACTx: Adjuvant chemotherapy.
- Citation: Jeon YW, Park IJ, Kim JE, Park JH, Lim SB, Kim CW, Yoon YS, Lee JL, Yu CS, Kim JC. Evaluating the benefit of adjuvant chemotherapy in patients with ypT0–1 rectal cancer treated with preoperative chemoradiotherapy. World J Gastrointest Surg 2021; 13(9): 1000-1011
- URL: https://www.wjgnet.com/1948-9366/full/v13/i9/1000.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v13.i9.1000